Protocol summary
-
Study aim
-
Determining the effect of time-restricted eating versus standard dietary advice on arterial stiffness indices in men with metabolic syndrome
-
Design
-
Clinical trial with control group, with parallel groups, without blinding, simple randomization, using sealed envelopes and random numbers with the help of Randomaize.com, on 48 patients
-
Settings and conduct
-
A meal containing 500 kcal (50% carbohydrates, 20% protein and 30% fat) will be provided at the beginning and end of the study. Then, in the fasting state, 60 minutes later and 120 minutes later, the blood sample is taken. Weight, height, waist circumference, bioelectrical impedance analysis (BIA), complete blood count (CBC), liver function (ALT, AST), CRP, lipid profile, glucose, insulin, insulin resistance, blood pressure, Pulse Wave Velocity (PWV) and indirect calorimetry will be evaluated at the beginning of the study and after 6 weeks. In the third week, weight, blood pressure, lipid profile, glucose, insulin and insulin resistance will be measured.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Men between the ages of 18 and 65, Body mass index (BMI) below 35, Specific work and sleep schedule, The duration of receiving daily food more than 14 hours, Diagnosis of metabolic syndrome according to the International Diabetes Federation (IDF) definition
Non-inclusion criteria: Diabetes, People being treated for hyperglycemia or hypercholesterolemia or hypertension, Thyroid disorders based on thyroid tests or thyroxine use, Eating disorders, Serious diseases that affect food intake such as cancer, Using supplements that contain compounds other than vitamins and minerals, Inability to follow time-restricted eating diet
-
Intervention groups
-
Intervention group: time-restricted diet (they will receive food in a 10-hour period.)
Control group: diet without time restriction
-
Main outcome variables
-
Pulse Wave Velocity (PWV)
General information
-
Reason for update
-
Due to the prolongation of the patient screening process (according to the inclusion and exclusion criteria) and the failure of some required devices, the sampling starts with a delay.
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT20201230049889N1
Registration date:
2022-08-14, 1401/05/23
Registration timing:
prospective
Last update:
2023-10-09, 1402/07/17
Update count:
1
-
Registration date
-
2022-08-14, 1401/05/23
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2023-10-23, 1402/08/01
-
Expected recruitment end date
-
2024-03-18, 1402/12/28
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
The Effect of Time-Restricted Eating versus Standard Dietary Advice on Arterial Stiffness Indices in Men with Metabolic Syndrome
-
Public title
-
The Effect of Time-Restricted Eating on Arterial Stiffness Indices in Patients with Metabolic Syndrome
-
Purpose
-
Supportive
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Men between the ages of 18 and 65
Body mass index (BMI) below 35
Diagnosis of metabolic syndrome according to the International Diabetes Federation (IDF) definition
Willingness to participate in the study by signing the informed consent form
Exclusion criteria:
Diabetes
Thyroid disorders based on thyroid tests or thyroxine use
Eating disorders
Serious diseases that affect food intake, such as cancer
Using supplements that contain compounds other than vitamins and minerals
Inability to follow time-restricted eating diet
Specific work and sleep schedule
The duration of receiving daily food less than 14 hours
-
Age
-
From 18 years old to 65 years old
-
Gender
-
Male
-
Phase
-
N/A
-
Groups that have been masked
-
No information
-
Sample size
-
Target sample size:
48
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
Randomization method: simple
Randomization Unit: Individual
Randomization tool: sealed envelope
(SNOSE: sequentially numbered, opaque, sealed envelopes)
How to make a random sequence: Randomaize.com randomization site
Explanation about allocation concealment: Random numbers are prepared with the help of Randomaize.com and printed and placed inside the envelope by a member of the research team. The lid of the envelopes will be closed and its contents will not be visible from the outside. Then first, the purpose of the study is explained to the person who meets the listed conditions. If desired, the person signs the informed consent form and takes an envelope. Then opens it and based on the contents of the envelope, the person is entered in the intervention or control group.
-
Blinding (investigator's opinion)
-
Not blinded
-
Blinding description
-
-
Placebo
-
Not used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2022-05-31, 1401/03/10
-
Ethics committee reference number
-
IR.MUMS.MEDICAL.REC.1401.213
Health conditions studied
1
-
Description of health condition studied
-
Metabolic syndrome
-
ICD-10 code
-
E88.81
-
ICD-10 code description
-
Metabolic syndrome
2
-
Description of health condition studied
-
Arterial stiffness indices
-
ICD-10 code
-
-
ICD-10 code description
-
3
-
Description of health condition studied
-
Time-restricted eating
-
ICD-10 code
-
-
ICD-10 code description
-
Primary outcomes
1
-
Description
-
Pulse wave velocity (PWV)
-
Timepoint
-
At the beginning of the study and after 6 weeks from the start of the study
-
Method of measurement
-
Pulse Wave Velocity device
Secondary outcomes
1
-
Description
-
Body weight
-
Timepoint
-
At the beginning of the study and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Scales
2
-
Description
-
Waist circumference
-
Timepoint
-
At the beginning of the study and 6 weeks after the start of the study
-
Method of measurement
-
Meter
3
-
Description
-
Body composition
-
Timepoint
-
At the beginning of the study and 6 weeks after the start of the study
-
Method of measurement
-
Bioelectric Impedance Analysis (BIA) device
4
-
Description
-
Complete blood count (CBC)
-
Timepoint
-
At the beginning of the study (fasting and 120 minutes after a meal) and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
5
-
Description
-
Alanine transaminase (ALT)
-
Timepoint
-
At the beginning of the study and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
6
-
Description
-
Aspartate transaminase (AST)
-
Timepoint
-
At the beginning of the study and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
7
-
Description
-
C-Reactive Protein (CRP)
-
Timepoint
-
At the beginning of the study (fasting and 120 minutes after a meal) and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
8
-
Description
-
Total cholesterol
-
Timepoint
-
At the beginning of the study and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
9
-
Description
-
Triglyceride
-
Timepoint
-
At the beginning of the study and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
10
-
Description
-
High-density lipoprotein (HDL)
-
Timepoint
-
At the beginning of the study and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
11
-
Description
-
Low-density lipoprotein (LDL)
-
Timepoint
-
At the beginning of the study and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
12
-
Description
-
Blood glucose
-
Timepoint
-
At the beginning of the study (fasting, 60 minutes after and 120 minutes after a meal) and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
13
-
Description
-
Insulin
-
Timepoint
-
At the beginning of the study (fasting, 60 minutes after and 120 minutes after a meal) and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Biochemical analysis of blood sample
14
-
Description
-
Insulin resistance
-
Timepoint
-
At the beginning of the study and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Calculation of Homeostatic Model Assessment (HOMA)
15
-
Description
-
Blood pressure
-
Timepoint
-
At the beginning of the study and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
Sphygmomanometer
16
-
Description
-
Metabolic rate
-
Timepoint
-
At the beginning of the study and 6 weeks after the start of the study
-
Method of measurement
-
Indirect calorimetry
17
-
Description
-
Appetite status
-
Timepoint
-
At the beginning of the study and 6 weeks after the start of the study
-
Method of measurement
-
Visual Analog Scale (VAS)
18
-
Description
-
Physical activity
-
Timepoint
-
3 days at the beginning of the study and 3 days at the end of the study
-
Method of measurement
-
Pedometer
19
-
Description
-
Sleep status
-
Timepoint
-
At the beginning of the study and 6 weeks after the start of the study
-
Method of measurement
-
Pitssburg Questionnaire
20
-
Description
-
Quality of life
-
Timepoint
-
At the beginning of the study and 6 weeks after the start of the study
-
Method of measurement
-
Short form of World Health Organization quality of life questionnaire (WHOQOL-BREF)
21
-
Description
-
Dietary intake
-
Timepoint
-
At the beginning of the study and 3 weeks and 6 weeks after the start of the study
-
Method of measurement
-
3-day 24-hour recall
Intervention groups
1
-
Description
-
Intervention group: In the intervention group, people will receive food in a period of 10 hours. It is recommended that this period be between 6 am and 8 pm. All foods and drinks except water, tea and coffee without added sweeteners should be consumed during this period. Due to not affecting the quality of sleep, tea and coffee consumption is allowed before 8 pm. With the help of researchers, participants will choose the best time frame that fits their life schedule. The patients' diet is according to their taste and freely, and there are no food restrictions. Participants will be explained about a healthy diet based on national dietary recommendations.
-
Category
-
Lifestyle
2
-
Description
-
Control group: The control group will have a diet without time restriction and will receive the necessary recommendations about a healthy diet based on national dietary guidelines. In this group, the diet of the patients is according to their taste and freely, and there are no food restrictions.
-
Category
-
N/A
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Mashhad University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Yes - There is a plan to make this available
-
Statistical Analysis Plan
-
Yes - There is a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Yes - There is a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Not applicable
-
Title and more details about the data/document
-
Some collected data including the results of primary outcome measures will be presented.
-
When the data will become available and for how long
-
Access to data will be granted 6 months after publication.
-
To whom data/document is available
-
Data will be accessible for people working in academic institutions and people working in businesses upon request.
-
Under which criteria data/document could be used
-
Criteria for sharing deidentified data or other products will be evaluated based on case-by-case approach by the Mashhad University of Medical Sciences.
-
From where data/document is obtainable
-
Dr. Mohsen Nemati
Address: Department of Nutrition, School of Medicine, Mashhad University of Medical Sciences, East door of Ferdowsi University, Azadi Sq., Mashhad Iran
Post code: 9177948564
Email: NematyM@mums.ac.ir
Phone number: 0098 51 38827034
-
What processes are involved for a request to access data/document
-
Applicants should submit their detailed request through email. Their request will be evaluated by the researchers and the Mashhad University of Medical Sciences and will be available to the applicant if approved by the organization.
-
Comments
-